Skip to main content

BioNTech SE (BNTX)

NASDAQ: BNTX · IEX Real-Time Price · USD
+2.02 (0.61%)
After-hours:Sep 24, 2021 7:59 PM EDT
-19.51 (-5.53%)
At close: Sep 24, 4:00 PM
Market Cap80.87B
Revenue (ttm)588.20M
Net Income (ttm)18.53M
Shares Out242.52M
EPS (ttm)18.14
PE Ratio18.39
Forward PE8.24
Ex-Dividend Daten/a
Previous Close352.99
Day's Range332.40 - 352.99
52-Week Range61.27 - 464.00
Price Target112.62 (-66.2%)
Est. Earnings DateNov 9, 2021

About BNTX

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is involved in the developing of FixVac product candidates, including BNT111, which is in Phase I clinical trial for advance melanoma; BNT112 that is in Phase I/IIa trial for prostate cancer; BNT113, which is in Phase I/II trial to treat HPV+ head and neck cancers; BNT114 that is in Phase I clinical trial for triple negative breast cancer; BNT115 in a Phase I trial in ovarian cancer; and BNT116 for non-small ce...

IPO DateOct 10, 2019
Stock ExchangeNASDAQ
Ticker SymbolBNTX
Full Company Profile

Financial Performance

Financial numbers in millions EURFinancial Statements

Analyst Forecast

According to 10 analysts, the average rating for BioNTech SE stock is "Buy." The 12-month stock price forecast is 112.62, which is a decrease of -66.23% from the latest price.

Price Target
(-66.23% downside)
Analyst Consensus: Buy


CDC approves Covid booster shots for those over 65

Anjalee Khemlani joins Yahoo Finance to break down the CDC's decision to support boosters for at-risk workers, vulnerable Americans, and seniors as surges of COVID continue to grip the nation. Don't Mis...

Other symbols:PFE
1 day ago - Yahoo Finance

CDC director endorses Pfizer booster for frontline workers, overruling advisory panel

The decision is in line with FDA authorization for booster shots of the Pfizer-BioNTech vaccine.

Other symbols:PFE
1 day ago - CNET

CDC director overrules advisors, expands booster recommendation

CNBC's Meg Tirrell reports on CDC director overruling advisers to expand Covid vaccine booster recommendation.

Other symbols:PFE
2 days ago - CNBC Television

Pfizer/BioNTech COVID-19 Boosters For Seniors, Certain Vulnerable Adults Coming Soon - CDC Panel Recommends

The Centers for Disease Control and Prevention (CDC) backed a booster shot of Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) COVID-19 vaccine for Americans aged 65 and older and adults with an un...

Other symbols:PFE
2 days ago - Benzinga

CDC Director Backs Pfizer Booster Shots For Seniors, Vulnerable—And High-Risk Workers

Dr. Rochelle Walensky recommended workers in high-risk settings to also be offered Pfizer Covid booster doses, despite the CDC advisers voting against this group getting the third shot.

Other symbols:PFE
2 days ago - Forbes

Will Pfizer ETFs Soar on FDA's COVID-19 Vaccine Booster Approval?

Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging update in coronavirus vaccine.

Other symbols:PFE
2 days ago - Zacks Investment Research

Why BioNTech Thrashed the Market on Thursday

With its latest ruling on the biotech's coronavirus vaccine, the FDA boosts the investment case for the stock.

2 days ago - The Motley Fool

CDC advisors vote to recommend Pfizer booster

Meg Tirrell joins Closing Bell with breaking news from a CDC advisory panel evaluating Covid booster shots.

Other symbols:PFE
2 days ago - CNBC Television

CDC panel recommends Pfizer booster for some people

Pfizer recipients 65 and older and those living in long-term care facilities would be eligible for a booster. People ages 18 to 64 with an underlying health condition would be eligible too.

Other symbols:PFE
2 days ago - CNET

Pfizer (PFE) Booster Dose Gets FDA Nod for High-Risk People

FDA approves Pfizer's (PFE) COVID-19 vaccine booster shots for older adults and high-risk people amid rising infection rates in the country.

Other symbols:PFE
2 days ago - Zacks Investment Research

EMA To Decide On Pfizer/BioNTech COVID-19 Booster Next Month: Reuters

The European Medicines Agency (EMA) expects to decide on the authorization for Pfizer Inc (NYSE: PFE) / BioNTech SE (NASDAQ: BNTX) COVID-19 booster shot at the beginning of October, Reuters reported cit...

Other symbols:PFE
2 days ago - Benzinga

Pfizer COVID-19 Vaccine Booster Shot Approved By FDA For High-Risk Individuals, People 65 And Up

The U.S. Food and Drug Administration on Wednesday authorized a booster dose of the Pfizer Inc. (NYSE: PFE)-BioNTech SE (NASDAQ: BNTX) COVID-19 vaccine for people aged 65 years and older as well as othe...

Other symbols:PFE
3 days ago - Benzinga

FDA Authorizes Pfizer Covid Booster Shots For Seniors And High-Risk Patients — But Not For All Americans

The FDA greenlit a third dose of Pfizer's coronavirus vaccine for seniors, people with underlying health conditions and people with “occupational exposure” to the coronavirus.

Other symbols:PFE
3 days ago - Forbes

FDA authorizes Pfizer's Covid booster shots for people 65 and older and other vulnerable Americans

The CDC's vaccine advisory committee plans to meet this week, and the agency's panel of experts is expected to vote on plans to distribute third shots.

Other symbols:PFE
3 days ago - CNBC

BioNTech SE Sponsored ADR (BNTX) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, BioNTech SE Sponsored ADR (BNTX) closed at $339.26, marking a -0.61% move from the previous day.

3 days ago - Zacks Investment Research

US to donate 500m extra vaccine shots - as Biden tells rich nations to share 'with no strings attached'

The US is buying a further 500 million COVID-19 vaccine doses to donate to other countries, bringing its total commitment to over a billion jabs, President Joe Biden has announced.

Other symbols:PFE
3 days ago - Skynews

Pfizer CEO on providing 500 million vaccines to low income countries

CNBC's "Squawk Box" team discusses the coronavirus vaccine and how it can get to lower income countries to provide equitable access and infrastructure with Pfizer CEO Albert Bourla.

Other symbols:PFE
4 days ago - CNBC Television

U.S. To Donate 500 Million More Pfizer Vaccine Doses To Poorer Countries

The deal doubles the country's existing commitment and brings the total number of doses it says it will share to 1 billion.

Other symbols:PFE
4 days ago - Forbes

US To Donate Additional 500M Pfizer-BioNTech COVID-19 Vaccine Doses To Lower Income Nations

Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) will provide the U.S. government additional 500 million doses of its COVID-19 vaccine. The doses at a not-for-profit price will be used for donation...

Other symbols:PFE
4 days ago - Benzinga

U.S. to donate millions more Pfizer-BioNTech vaccine doses to poorer nations

Pfizer and BioNTech will provide an additional 500 million doses of their Covid-19 vaccine to the U.S. government to be donated to lower income countries.

Other symbols:PFE
4 days ago - CNBC

Pfizer and BioNTech Expand Collaboration with U.S. to Provide 500 Million Additional COVID-19 Vaccine Doses at Not-Fo...

NEW YORK and MAINZ, Germany, September 22, 2021— Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced plans to expand their agreement with the U.S. government by ...

4 days ago - GlobeNewsWire

FDA To Probably Decide On Pfizer/BioNTech COVID-19 Booster Shots By Tomorrow: Bloomberg

Citing people familiar with the matter, Bloomberg reports that the FDA is expected to decide on Wednesday whether to recommend Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) COVID-19 vaccine as a...

Other symbols:PFE
4 days ago - Benzinga

For BioNTech, the COVID-19 vaccine was simply the opening act

Ultimately, BioNTech's mission is to make treatments that are optimized not only to specific patient needs, but also to time and place.

4 days ago - TechCrunch

2 Outperforming Biotech Stocks to Examine on Covid-19 Vaccine Updates

With recent updates from Pfizer Inc. ( PFE , Financial) and BioNTech SE ( BNTX , Financial) regarding the effectiveness of their Covid-19 vaccine among children ages 5 to 11 and Johnson & Johnson's ( JN...

4 days ago - GuruFocus